Durect: Injectable Risperidone Product Patent Transaction


Back to Market   点击查看专利   Bid-Ask™ Market Brochure


Public Patent Transaction 0199 on Ocean Tomo Bid-Ask™ Market

Public Patent Transaction Durect injectable risperidone product patents sold for $12.5 million

Public Patent Transaction, 0199 reported on the Ocean Tomo Bid-Ask™ Market relates to a divestiture of an undisclosed number of patents. Durect sold the injectable risperidone product patents to Indivior for $12.5 million.

Patent Resource Link